SCHEMBL5952463

SCHEMBL5952463

O=C1c2c(Cl)cccc2CC1c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.50
PBRM1 Q86U86 1/20 0.42
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
CYP19A1 P11511 3/20 0.39
CFTR P13569 1/20 0.37
GOPC Q9HD26 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
EEF2K O00418 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
AADAT Q8N5Z0 1/20 0.35
SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14939509 0.80 SLC6A2 (0.44) NOS3HTR2AHTR2CHTR2BCYP19A1
SCHEMBL14939858 0.80 NOS3 (0.50) NOS3CYP19A1CFTRGOPCTSHR
SCHEMBL14939628 0.76 KDM4E (0.50) HTR2AHTR2CHTR2BCYP19A1ADRA1D
SCHEMBL7633386 0.75 HTR2A (0.43) NOS3HTR2AHTR2CHTR2BAADAT
SCHEMBL19899064 0.74 NOS3 (0.43) NOS3HTR2AHTR2CHTR2BKMT2A
SCHEMBL5951341 0.74 ACHE (0.52) NOS3HTR2AHTR2CHTR2BADRA1D
SCHEMBL5951729 0.73 CYP19A1 (0.45) HTR2BCYP19A1CFTRGOPCTSHR
SCHEMBL5951328 0.73 ABCB1 (0.50) NOS3CYP19A1SIGMAR1
SCHEMBL30785363 0.73 ACHE (0.55) NOS3HTR2BCYP19A1SIGMAR1
SCHEMBL2345374 0.73 ACHE (0.55) NOS3HTR2BCYP19A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
EP-0968158-A1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM Basell Polyolefine GmbH (DE) 2000-01-05 EP disclosed
WO-1998040331-A1 PREPARATION OF PREPARING SUBSTITUTED INDANONES TARGOR GMBH (DE) 1998-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A NOS3 784/4885PBRM1 3711/4885HTR2A 2569/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 NOS3 792/4885PBRM1 3474/4885HTR2A 2727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.